Trian urges Solventum to rightsize costs, divest non-core businesses
30/04/2026 18:17
April 30 (Reuters) - Trian Fund Management, which owns nearly 5% of Solventum SOLV.N stock, on Thursday called the medical device maker to rightsize overhead costs, divest non-core businesses and improve capital allocation. (Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Solventum
See all newsSolventum Corporation reports results for the quarter ended June 30 - Earnings Summary
Solventum to hive off healthcare software business, raises profit forecast
Solventum Q2 sales, adjusted EPS beat estimates; FY outlook lifted
Solventum Corp expected to post earnings of $1.91 a share - Earnings Preview
Solventum forecasts annual profit at higher end on wound care demand